Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY(2024)
关键词
cancer,immune checkpoint inhibitors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要